Hospitals See Danger to SDPs in Fraud Fight

Why It Matters

SDPs represent billions of dollars in supplemental Medicaid funding; limiting them could strain hospital finances and reduce access for vulnerable patients. The outcome will shape how states and providers balance fraud prevention with essential care delivery.

Key Takeaways

• CMS RFI may tighten rules on Medicaid SDPs and IGT financing.
• Hospital groups warn restrictions could cut reimbursement and strain care delivery.
• FAH proposes transparency over new administrative burdens for SDP oversight.
• AI-driven fraud tools face skepticism over reliability and provider impact.
• Proposed Medicare claim filing changes could increase administrative load for hospitals.

Pulse Analysis

State‑directed payments (SDPs) have become a cornerstone of Medicaid financing, allowing states to supplement federal funds with mechanisms such as intergovernmental transfers, provider taxes or hospital‑level levies. In 2023, the Government Accountability Office highlighted weak fiscal guardrails and limited transparency around these payments, prompting Congress to embed some reforms in the One Big Beautiful Bill Act. The current CMS request for information (RFI) under the CRUSH initiative signals a possible federal push to tighten oversight, a move that could reshape how billions of dollars flow to safety‑net hospitals.

Hospital coalitions are pushing back, emphasizing that additional restrictions could erode reimbursement streams that already fall short of covering service costs. Organizations like America’s Essential Hospitals and the Healthcare Association of New York State argue that existing federal and state oversight provides sufficient safeguards, and that new reporting requirements would divert resources from direct patient care. The Federation of American Hospitals instead advocates for greater transparency—public dashboards, standardized reporting, and clearer audit trails—rather than blanket financing caps. Meanwhile, the sector remains wary of expanding AI‑driven fraud tools, citing concerns over accuracy, coder displacement, and unintended financial penalties.

The ripple effects extend beyond Medicaid. Proposals to shorten Medicare claim filing windows from one year to as little as 90 days, and to grant Medicare Advantage plans authority to suspend payments for suspected fraud, could impose steep administrative burdens on providers. Hospitals fear that such changes, combined with stricter SDP rules, may trigger cash‑flow challenges and limit access for low‑income patients. As policymakers weigh fraud mitigation against care continuity, the dialogue underscores a broader tension: safeguarding program integrity without undermining the financial viability of the hospitals that serve America’s most vulnerable populations.